Evidence needs for licensing and reimbursement
No abstract is available for this item.
|Date of creation:||2013|
|Date of revision:|
|Contact details of provider:|| Phone: Charles Thackrah Building, 101 Clarendon Road, LEEDS LS9 2LJ|
Fax: +44 (0) 113 343 3470
Web page: http://medhealth.leeds.ac.uk/auhe
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Christopher J. McCabe & Tania Stafinski & Richard Edlin & Devidas Menon, 2010. "Access with Evidence Development Schemes: A Framework for Description and Evaluation," PharmacoEconomics, Springer Healthcare | Adis, vol. 28(2), pages 143-152.
- Claxton, Karl, 1999. "The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies," Journal of Health Economics, Elsevier, vol. 18(3), pages 341-364, June.
- Allan Wailoo & Aki Tsuchiya & Christopher McCabe, 2009. "Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected," PharmacoEconomics, Springer Healthcare | Adis, vol. 27(12), pages 983-989.
- Jan Abel Olsen & Richard D. Smith, 2001. "Theory versus practice: a review of 'willingness-to-pay' in health and health care," Health Economics, John Wiley & Sons, Ltd., vol. 10(1), pages 39-52.
When requesting a correction, please mention this item's handle: RePEc:lee:wpaper:1301. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Judy Wright)
If references are entirely missing, you can add them using this form.